ask="3.00"
ask_size="700"
average_daily_volume="46579"
bid="1.75"
bid_size="500"
book_value="2.84"
change="+0.20"
change_from_200_day_moving_average="-1.37"
change_from_50_day_moving_average="-0.27"
change_from_52_week_high="-3.59"
change_From_52_week_low="0.80"
change_in_percent="+7.69%"
close="2.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.04"
ebitda="-37.85M"
eps_estimate_current_year="-1.86"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.19"
ex_dividend_date="N/A"
float_shares="12476000"
high="2.85"
high_52_weeks="6.39"
last_trade_date="1/17/2017"
last_trade_price="2.80"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.55"
low_52_weeks="2.00"
market_capitalization="59.37M"
moving_average_200_day="4.17"
moving_average_50_day="3.07"
name="Strongbridge Biopharma plc - Or"
notes="N/A"
one_year_target_price="13.33"
open="2.60"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-32.87%"
percent_change_from_50_day_moving_average="-8.85%"
percent_change_from_52_week_high="-56.18%"
percent_change_from_52_week_low="+40.00%"
previous_close="2.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.91"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="0.50"
stock_exchange="NMS"
symbol="SBBP"
volume="236683"
weeks_range_52="2.00 - 6.39"
